News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

Do supplements measure up to statins for lipid-lowering?
13 Dec 2022
byAudrey Abella
In individuals with increased 10-year risk for ASCVD*, rosuvastatin 5 mg significantly reduced LDL-C** and other lipid and inflammatory biomarkers compared with placebo and six widely used heart health supplements, results from the SPORT*** trial have shown.
13 Dec 2022

Low-dose polypill: Another step forward in hypertension management?
12 Dec 2022
byRoshini Claire Anthony
A polypill comprising ultra-low doses of four antihypertensive drugs shows promise in reducing blood pressure (BP) levels compared with standard monotherapy, according to a small study presented at AHA 2022.
12 Dec 2022

CV benefits of dapagliflozin evident regardless of baseline kidney function
11 Dec 2022
byRoshini Claire Anthony
The cardiovascular (CV) benefit of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) is evident regardless of baseline kidney function, according to an analysis of the DELIVER* trial presented at Kidney Week 2022.
11 Dec 2022





